Klow
klow stack is a multi-peptide research blend formulated with BPC-157, TB-500, GHK-Cu, and KPV. This combination is commonly studied in laboratory settings for its potential interaction with cellular repair pathways, tissue response models, inflammatory signaling, copper peptide activity, and extracellular matrix research.
Each KLOW formulation contains 10 mg BPC-157, 10 mg TB-500, 50 mg GHK-Cu, and 10 mg KPV. These peptides are of research interest due to their individual relevance in studies involving tissue remodeling, angiogenic signaling, cellular migration, collagen-related pathways, and immune-response models. When examined together, the blend provides a broader platform for researchers studying complementary peptide activity within controlled environments.
Certificate Of Analysis

Klow Peptide in Canada
Polar Peptides supplies Klow peptide in Canada as a lyophilised four-component research blend. The sealed vial contains 80mg of total material. You can order one vial or choose a 3-vial or 10-vial pack. Klow combines BPC-157, TB-500, GHK-Cu, and KPV in one vial. Therefore, laboratories can study several peptide pathways within one preparation.
About the Klow Blend
Klow contains four peptide components in one vial. These include 10mg BPC-157, 10mg TB-500, 50mg GHK-Cu, and 10mg KPV. Each sequence has its own characterisation. However, the combined format gives laboratories access to four components in one research material.
Furthermore, this format can support studies that examine several pathways in parallel. Instead of working with four separate vials, researchers can use one defined blend for suitable comparative research.
Most importantly, KPV distinguishes this combination from narrower peptide blends. The other three sequences feature mainly in research involving tissue signalling and matrix components. In contrast, researchers investigate KPV as an alpha-MSH fragment in inflammatory-pathway models.
As a result, Klow brings four different peptide sequences together in one preparation. This combination can broaden the range of research models that laboratories can examine.
Key Research Areas
- Four-way peptide interaction studies within a single preparation
- Inflammatory-pathway signalling involving the KPV fragment
- Extracellular matrix and tissue-remodelling research models
- Copper-binding peptide activity alongside non-metal sequences
- Comparative research against narrower three-component blends
Specifications
- Format: Lyophilised multi-peptide blend in a sealed research vial
- Size available: 80mg
- Pack options: 1 vial, 3 vials, or 10 vials
- Blend composition: 10mg BPC-157, 10mg TB-500, 50mg GHK-Cu, and 10mg KPV per vial
- Stated purity: 99%+
Component Peptides and the Pre-Mixed Format
Each sequence in the Klow vial is also available separately. Therefore, researchers can select individual components when a study requires one sequence in isolation. These include BPC-157, TB-500, GHK-Cu, and KPV.
In addition, Polar Peptides offers the identical formulation as a Klow Pre-Mixed Pen. Unlike the lyophilised vial, the pen provides the blend in a ready-prepared solution.
As a result, researchers can compare the lyophilised blend with the pre-mixed presentation according to their laboratory requirements.
Frequently Asked Questions
What is in each Klow vial?
Each 80mg vial contains 10mg BPC-157, 10mg TB-500, 50mg GHK-Cu, and 10mg KPV.
Can Klow be ordered in multiples?
Yes. You can order the 80mg Klow vial individually. Alternatively, you can choose a 3-vial pack or 10-vial pack.
How does the Klow vial differ from the pre-mixed pen?
The Klow vial contains a lyophilised blend. Meanwhile, the Klow Pre-Mixed Pen contains the same four components in a prepared solution. Therefore, the two formats provide different presentation options for laboratory research.
Finally, Klow is supplied strictly for research use only. Polar Peptides intends this product for qualified laboratory, analytical, or educational research appl









